
Beta Bionics Faces Securities Lawsuit Over Alleged Insulin Pump Failures
Investors who lost over $100,000 in Beta Bionics stock between July 2025 and February 2026 face a November 3, 2026, deadline to apply as lead plaintiffs in a class action lawsuit. The case centers on claims that the company concealed dangerous malfunctions in its flagship iLet Bionic Pancreas device.

























:format(webp)/nginx/o/2024/05/09/16059172t1h7267.jpg)
